Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A1NU
|
||||
Former ID |
DCL001101
|
||||
Drug Name |
ABT-279
|
||||
Synonyms |
LS-193221
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 1 | [548377] | ||
Company |
Abbott Lab
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H25N5O3
|
||||
Canonical SMILES |
CC1(CCN(CC1)C2=NC=CC(=C2)C(=O)O)NCC(=O)N3C(CCC3C#N)C#C
|
||||
InChI |
1S/C21H25N5O3/c1-3-16-4-5-17(13-22)26(16)19(27)14-24-21(2)7-10-25(11-8-21)18-12-15(20(28)29)6-9-23-18/h1,6,9,12,16-17,24H,4-5,7-8,10-11,14H2,2H3,(H,28,29)/t16-,17-/m0/s1
|
||||
InChIKey |
FIMRNLAKAARHPD-IRXDYDNUSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [537022] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.